Mri s/o hyperintentensity in bl temporal and cerebellar lobe with 2 Yr History of progressive cerebellar sym diagnosis
bilateral temporal cerebellar hyperintensity MRI progressive ataxia diagnosis
autoimmune cerebellar ataxia temporal lobe encephalitis MRI T2 hyperintensity
progressive cerebellar ataxia temporal lobe T2 hyperintensity differential diagnosis
autoimmune cerebellar ataxia antibody mediated treatment review
immune-mediated cerebellar ataxia diagnosis antibodies MRI findings
bilateral temporal cerebellar T2 FLAIR hyperintensity progressive ataxia 2 years differential diagnosis MRI
| Feature | Detail |
|---|---|
| Pathology | Autoantibodies against neural surface or intracellular antigens |
| MRI | Bilateral mesial temporal T2/FLAIR hyperintensity (limbic) + cerebellar changes |
| Course | Can be subacute to chronic progressive over months–years |
| Key antibodies | Anti-Hu (ANNA-1), Anti-Yo (PCA-1), Anti-Ri, anti-VGCC, anti-CASPR2, anti-LGI1, anti-NMDAR, anti-GAD65 |
| Feature | Detail |
|---|---|
| Classic MRI | Bilateral medial temporal lobe T2/FLAIR hyperintensity — hallmark finding |
| Antibodies | Anti-LGI1, anti-CASPR2, anti-NMDAR, anti-AMPAR, anti-GABA-B |
| Cerebellar involvement | Anti-GABA-B and anti-CASPR2 subtypes especially can extend to cerebellum |
| Associated | Seizures, amnesia, psychiatric symptoms, confusion |
| Feature | Detail |
|---|---|
| MELAS | Stroke-like episodes, bilateral cortical/temporal signal changes |
| POLG | Progressive ataxia, COX-deficient fibers on muscle biopsy, cerebellar involvement |
| Maternal inheritance / de novo | |
| MRI | Asymmetric cortical/subcortical, temporal > occipital in MELAS; cerebellar atrophy in POLG |
STEP 1 — MRI Review
├── Confirm: Bilateral medial temporal T2/FLAIR hyperintensity?
├── Cerebellar: atrophy, white matter signal, MCP sign?
├── DWI: restricted diffusion? (CJD, stroke)
├── Enhancement pattern: perivascular (CLIPPERS), nodular, leptomeningeal?
└── Temporal pole involvement (CADASIL)?
STEP 2 — Blood Tests
├── Paraneoplastic panel: Anti-Hu, Anti-Yo, Anti-Ri, Anti-CV2, Anti-Ma2, Anti-VGCC
├── Autoimmune encephalitis: Anti-LGI1, Anti-CASPR2, Anti-NMDAR, Anti-GABA-B
├── Anti-GAD65 (high titre)
├── Thyroid antibodies (anti-TPO, anti-TG) → Hashimoto encephalopathy
├── Anti-gliadin, anti-TG6, anti-tTG → Gluten ataxia / celiac
├── ANA, dsDNA, ANCA, ACE → Lupus, vasculitis, sarcoidosis
├── Mitochondrial: lactate, pyruvate, genetic testing (POLG, MTTL1)
├── FMR1 premutation screen (males, family history)
└── HIV, RPR/VDRL, Lyme serology
STEP 3 — CSF Analysis
├── Cell count, protein, glucose, IgG index, oligoclonal bands
├── Paraneoplastic + autoimmune antibody panel (CSF more sensitive for some)
├── 14-3-3 protein, total tau, RT-QuIC (if CJD suspected)
├── Culture, PCR (HSV, EBV, JCV, VZV, CMV)
└── Cytology + flow cytometry (CNS lymphoma)
STEP 4 — Oncology Screening
├── CT chest/abdomen/pelvis (lung, ovarian, breast cancer)
├── PET-CT if CT negative and paraneoplastic suspected
└── Testicular ultrasound in young males
STEP 5 — Tissue / Special
├── Muscle biopsy with COX/SDH stain if mitochondrial suspected
├── Skin biopsy for CADASIL (NOTCH3 electron microscopy)
└── Brain biopsy if all else negative and steroid trial fails
Beaver sign and causes and dd
Beaver sign neurology clinical sign causes differential diagnosis
"Beaver sign" neurology neck flexion weakness
"Beevor sign" facioscapulohumeral dystrophy spinal cord
https://www.ncbi.nlm.nih.gov/books/NBK545262/
Note: The correct spelling is Beevor's sign (named after British neurologist Charles Edward Beevor, 1854–1908). "Beaver sign" is a common phonetic misspelling in clinical settings.
| Segment | Innervates |
|---|---|
| T7–T9 | Upper rectus abdominis |
| T10–T12 | Lower rectus abdominis |
| Observation | Interpretation |
|---|---|
| Umbilicus moves up >1 cm | Positive Beevor's sign → lower abdominal weakness (T10–T12) |
| Umbilicus remains stationary | Negative (normal) |
| Umbilicus moves down >1 cm | Inverted Beevor's sign → upper abdominal weakness (T7–T9) |
| Umbilicus shifts laterally | Extended Beevor's sign → asymmetric paraspinal/rectus atrophy (one side) |
| Condition | Notes |
|---|---|
| Spinal cord tumor (T10–T12) | First described by Beevor in a patient with T11–T12 tumor |
| Spinal cord trauma / transection | Cord injury at T9–T10 level |
| Spinal cord infarction | Acute presentation; vascular lesion below T10 |
| Transverse myelitis | Inflammatory/demyelinating at thoracic level |
| Multiple sclerosis | Demyelinating plaques at T9–T12 |
| Epidural abscess/hematoma | Compressive cord lesion |
| HTLV-1 myelopathy | Tropical spastic paraparesis |
| Condition | Mechanism |
|---|---|
| Diabetic truncal neuropathy | Segmental thoracic root involvement at T10–T12 |
| Thoracic radiculopathy | Infiltrative (metastatic), inflammatory, or compressive |
| Post-herpetic thoracic mononeuropathy | Segmental T10–T12 injury |
| Feature | Spinal Cord Lesion | FSHD |
|---|---|---|
| Onset | Acute or subacute | Insidious, decades |
| Sensory level | Present (T9–T10) | Absent |
| Paraplegia / UMN signs | Present | Absent |
| Facial weakness | Absent | Present (orbicularis) |
| Scapular winging | Absent | Classic feature |
| Family history | Absent | AD inheritance (4q35 deletion) |
| CK | Normal | Mildly–moderately elevated |
| EMG | Neurogenic | Myopathic |
| MRI spine | Cord lesion visible | Normal |
Border zone infarct watershed territory and clinical presentation with ocular manifestations and causes